Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofCytarabine Injectionfrom Surat, Gujarat, India. Cytarabine Injection used in the treatment of acute myeloid leukaemia, acute lymphocytic leukaemia (ALL) and in lymphomas.
Tags: Cytarabine Injection manufacturer, Cytarabine Injection exporter,Cytarabine Injection supplier, and Cytarabine Injection, whogmp approved Cytarabine Injectionmanufacturer and supplier, Cytarabine Injection distributor, Cytarabine Injectionshipper, Cytarabine Injection 10 ml Cytarabine Injection 10 ml supplier,Cytarabine Injection 10 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility inGujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Cytarabine Injection Exportto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Applications in Leukemia and Lymphoma TherapyCytarabine injection is widely recognized for its efficacy in treating certain blood cancers, particularly acute myeloid leukemia (AML) and lymphomas. Its mechanism of action involves impeding the replication of malignant cells, leading to improved patient outcomes. The formulation is commonly administered under medical supervision, ensuring optimal absorption and therapeutic benefit for individuals diagnosed with these life-threatening conditions.
Assured Quality and Safety StandardsThis cytarabine injection adheres to stringent USP pharmacopoeial standards, ensuring consistent quality, sterility, and safety. The preparation is housed in high-quality Type I glass vials to preserve integrity and minimize contamination risks. Users can rely on the product's pharmacological effectiveness, neutral pH, and stable composition for safe and predictable administration.
Flexible Administration and StorageDesigned for versatility, the cytarabine injection can be delivered intravenously, subcutaneously, or intrathecally, as per healthcare provider's direction. With a shelf life of two years, the product remains stable when stored properly in a cool and dry place. Its clear, colorless solution and normal fermentation smell further assure users of its high manufacturing standards.
FAQ's of cytarabine injection:
Q: How should cytarabine injection be administered?
A: Cytarabine injection can be administered intravenously, subcutaneously, or intrathecally, depending on the prescribed treatment plan. The specific route and dosage will be determined by a healthcare professional based on your condition.
Q: What conditions is cytarabine injection commonly used to treat?
A: Cytarabine injection is primarily indicated for the treatment of certain leukemias, such as acute myeloid leukemia, and may also be used in some lymphomas. Your doctor will determine its suitability for your diagnosis.
Q: When should cytarabine injection be used during treatment?
A: Cytarabine injection is typically administered as part of a structured chemotherapy regimen, with timing, frequency, and duration tailored to the patient's specific medical situation by their oncologist.
Q: Where should I store the cytarabine injection vials?
A: The vials should be stored in a cool, dry place, away from direct sunlight or excess heat to maintain the medication's stability throughout its two-year shelf life.
Q: What is the process for ensuring cytarabine injection's sterility and safety?
A: Each vial is produced under sterile conditions, meets USP standards, and is contained in Type I glass to prevent contamination. The single-use format further reduces any risk of infection or deterioration.
Q: Who can provide cytarabine injection in India?
A: Cytarabine injection can be sourced from licensed dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India. Being a prescription medication, it should be acquired with a valid prescription from a healthcare provider.
Q: What are the benefits of using cytarabine injection for leukemia or lymphoma?
A: Cytarabine injection interferes with the replication of cancerous cells, contributing to disease management and improved treatment outcomes for patients with specific leukemias and lymphomas.